However, in a study, the anti-MDA5 and anti-TIF1, as well as anti-NXP2 antibodies were associated with calcinosis in a cohort of JDM patients [11], and JDM onset within 6 years of age was a predictive factor for the development of calcinosis [11]. This evidence concerns the gene TRIM24 and juvenile dermatomyositis.